Outcomes of neoadjuvant gemcitabine plus S-1 and radiation therapy for borderline resectable pancreatic cancer.
Yasuhiro YabushitaRyusei MatsuyamaKentaro MiyakeYuki HommaTakafumi KumamotoToshihiro MisumiMasaharu HataShoji YamanakaSatoshi FujiiItraru EndoPublished in: Journal of hepato-biliary-pancreatic sciences (2022)
This study was registered with the University Hospital Medical Information Network-Clinical Trials Registry (UMIN-CTR) UMIN000006782.